Muhammad Aqib Shabbir

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Convolutional Neural Network

Chronic Myeloid Leukemia

Top Venues

Bioengineering (Basel, Switzerland)

Prehospital and disaster medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Naveed, Noor Ul Ain, Tariq Aziz, Khushbakht Javed, Muhammad Aqib Shabbir, Metab Alharbi, Abdulrahman Alshammari, Abdullah F AlAsmari
Artificial Intelligence Assisted Pharmacophore Design for Philadelphia Chromosome-Positive Leukemia with Gamma-Tocotrienol: A Toxicity Comparison Approach with Asciminib. Biomedicines 11 (4) (2023)
Muhammad Naveed, Noor Ul Ain, Tariq Aziz, Khushbakht Javed, Muhammad Aqib Shabbir, Metab Alharbi, Abdulrahman Alshammari, Abdullah F AlAsmari
Artificial Intelligence Assisted Pharmacophore Design for Philadelphia Chromosome-Positive Leukemia with Gamma-Tocotrienol: A Toxicity Comparison Approach with Asciminib. Biomedicines 11 (4) (2023)
Muhammad Naveed, Muhammad Aqib Shabbir, Noor-Ul Ain, Khushbakht Javed, Sarmad Mahmood, Tariq Aziz, Ayaz Ali Khan, Ghulam Nabi, Muhammad Shahzad, Mousa Essa Alharbi, Metab Alharbi, Abdulrahman Alshammari
Chain-Engineering-Based De Novo Drug Design against MPXVgp169 Virulent Protein of Monkeypox Virus: A Molecular Modification Approach. Bioengineering (Basel, Switzerland) 10 (1) (2022)
Muhammad Aqib Shabbir, Muhammad Naveed, Muhammad Farrukh Asif, Amna Shahid, Noor-Ul- Ain, Sarmad Mahmood, Umm-E- Laila, Muhammad Junaid Iftikhar
Dissemination of Water-Mediated Infections due to Torrential Rainfalls Leading to Havoc Floods: A Dreadful Curve for Pakistan. Prehospital and disaster medicine 37 (6) (2022)
Muhammad Naveed, Muhammad Aqib Shabbir, Noor-Ul Ain, Khushbakht Javed, Sarmad Mahmood, Tariq Aziz, Ayaz Ali Khan, Ghulam Nabi, Muhammad Shahzad, Mousa Essa Alharbi, Metab Alharbi, Abdulrahman Alshammari
Chain-Engineering-Based De Novo Drug Design against MPXVgp169 Virulent Protein of Monkeypox Virus: A Molecular Modification Approach. Bioengineering (Basel, Switzerland) 10 (1) (2022)